Campbell David Alan
Janux Therapeutics, Inc. · President and CEO
Campbell David Alan is listed in filings as President and CEO at Janux Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 2, 2026, including sale activity. Recent filings connect the profile to Janux Therapeutics, Inc. (JANX). The current snapshot covers public activity from Sep 27, 2024 to Jan 2, 2026. Reported amounts are shown as $4.6M to $300.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $300k5k shares | SellJan 7, 2025 | $60.00 | $15.84 | |
| $1M25k shares | SellDec 24, 2024 | $56.19 | $15.84 | |
| $1M15k shares | SellDec 3, 2024 | $67.00 | $15.84 | |
| $940k18.3k shares | SellNov 25, 2024 | $51.43 | $15.84 | |
| $350k6.7k shares | SellNov 25, 2024 | $52.04 | $15.84 | |
| $740k13.9k shares | SellOct 28, 2024 | $53.22 | $15.84 | |
| $599k11.1k shares | SellOct 28, 2024 | $53.94 | $15.84 | |
| $874k19k shares | SellSep 27, 2024 | $46.09 | $15.84 | |
| $246k5.2k shares | SellSep 27, 2024 | $46.86 | $15.84 | |
| $38k795 shares | SellSep 27, 2024 | $47.84 | $15.84 |